Jefferies analyst Matthew Stanton assumes CryoPort (NASDAQ:CYRX) with a Buy rating and raises Price Target to $21.
Jefferies Assumes CryoPort at Buy, Raises Price Target to $21
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.